Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial

American Medical Association, Journal of the American Medical Association, 8(318), p. 748

Journal article published in 2017 by Dhruv S. Kazi, Joanne Penko, Pamela G. Coxson, Andrew E. Moran, Daniel A. Ollendorf, Jeffrey A. Tice

, Kirsten Bibbins-Domingo

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by